1. Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy
    Yu Wang et al, 2017, Medicine CrossRef
  2. A magasabb vérlemezkeszám mint a fej-nyak tumoros betegek túléléssel kapcsolatos esetleges prognosztikai faktora
    Zsuzsanna Szilasi et al, 2021, Orvosi Hetilap CrossRef
  3. Pre-Treatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Occult Cervical Metastasis in Clinically Negative Neck Supraglottic and Glottic Cancer
    Giovanni Salzano et al, 2021, Journal of Personalized Medicine CrossRef
  4. MRI-based radiomics models can improve prognosis prediction for nasopharyngeal carcinoma with neoadjuvant chemotherapy
    Fan Zeng et al, 2022, Magnetic Resonance Imaging CrossRef
  5. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio
    Mario Turri-Zanoni et al, 2017, Head & Neck CrossRef
  6. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
    Yun-Hsuan Lin et al, 2018, Radiation Oncology CrossRef
  7. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma
    Laura Pardo et al, 2017, Auris Nasus Larynx CrossRef
  8. Establishment of a prognostic nomogram for patients with locoregionally advanced nasopharyngeal carcinoma incorporating clinical characteristics and dynamic changes in hematological and inflammatory markers
    Qin Liu et al, 2022, Frontiers in Oncology CrossRef
  9. Platelet count and breast cancer stage
    Andi Fahdrin et al, 2023, Breast Disease CrossRef
  10. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio
    Wei Sun et al, 2016, Head & Neck CrossRef
  11. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma
    Li Su et al, 2017, Medicine CrossRef
  12. Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma
    XueCheng Xie et al, 2017, Oncotarget CrossRef
  13. The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan
    Kazumasa Komura et al, 2019, Annals of Surgical Oncology CrossRef
  14. Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first-line treatment of recurrent or metastatic nasopharyngeal carcinoma
    Xudong Chen et al, 2019, Oral Oncology CrossRef
  15. Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma
    Lu‐Lu Zhang et al, 2023, Cancer Medicine CrossRef